Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203Yoko Tsukita, Masakazu Ichinose, Toshiyuki Harada et al.|Lung Cancer|2019Cited by 27
Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 TrialsToshiyuki Harada, Masaharu Nishimura, Toraji Amano et al.|Frontiers in Pharmacology|2018Cited by 19
Phase II Study of Low-Dose Afatinib Maintenance Treatment Among Patients with <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1601 (NJLCG1601)Atsushi Nakamura, Shunichi Sugawara, Hisashi Tanaka et al.|The Oncologist|2020Cited by 6
Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001Makoto Maemondo, Kana Watanabe, Yukihiro Toi et al.|Translational Lung Cancer Research|2021Cited by 6
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Nobuhiko Seki, Shigeru Tanzawa et al.|JTO Clinical and Research Reports|2023Cited by 5